These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6993358)

  • 21. Role of the renal nerves in the pathogenesis of one-kidney renal hypertension in the rat.
    Katholi RE; Winternitz SR; Oparil S
    Hypertension; 1981; 3(4):404-9. PubMed ID: 7030950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
    Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
    O'Donaughy TL; Brooks VL
    Hypertension; 2006 Apr; 47(4):680-5. PubMed ID: 16520400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retardation of the development of hypertension in DOCA salt rats by taurine supplement.
    Inoue A; Takahashi H; Lee LC; Sasaki S; Kohno Y; Takeda K; Yoshimura M; Nakagawa M
    Cardiovasc Res; 1988 May; 22(5):351-8. PubMed ID: 3191519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment of neurally-mediated vasoconstriction in DOCA-salt hypertensive dogs.
    Hamed AT; Lokhandwala MF
    Clin Exp Hypertens A; 1982; 4(6):867-81. PubMed ID: 6284412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage depletion lowers blood pressure and restores sympathetic nerve α2-adrenergic receptor function in mesenteric arteries of DOCA-salt hypertensive rats.
    Thang LV; Demel SL; Crawford R; Kaminski NE; Swain GM; Van Rooijen N; Galligan JJ
    Am J Physiol Heart Circ Physiol; 2015 Oct; 309(7):H1186-97. PubMed ID: 26320034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of hypothalamo-sympathetic hyperactivity by renal denervation in experimental hypertensive rats.
    Takeda K; Okajima H; Hayashi J; Kawasaki S; Sasaki S; Nakagawa M; Ijichi H
    Clin Exp Hypertens A; 1987; 9 Suppl 1():75-88. PubMed ID: 3677459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary excretion of digoxin-like factor (DLF) and ADH during DOCA-salt and Goldblatt 2 kidney-1 clip hypertension development.
    Vargas F; Casanova I; Haro JM; Luna JD; Garcia del Rio C
    Horm Metab Res; 1990 Jun; 22(6):352-5. PubMed ID: 2199365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diverse effects of renal denervation on ventricular hypertrophy and blood pressure in DOCA-salt hypertensive rats.
    Cabral AM; Silva IF; Gardioli CR; Mauad H; Vasquez EC
    Braz J Med Biol Res; 1998 Apr; 31(4):587-90. PubMed ID: 9698814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
    Nakata T; Takeda K; Itho H; Hirata M; Kawasaki S; Hayashi J; Oguro M; Sasaki S; Nakagawa M
    Am J Hypertens; 1989 Aug; 2(8):625-30. PubMed ID: 2570597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat.
    Banek CT; Gauthier MM; Baumann DC; Van Helden D; Asirvatham-Jeyaraj N; Panoskaltsis-Mortari A; Fink GD; Osborn JW
    Am J Physiol Regul Integr Comp Physiol; 2018 Jun; 314(6):R883-R891. PubMed ID: 29513561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats.
    Theriot JA; Passmore JC; Jimenez AE; Fleming JT
    J Lab Clin Med; 2000 Jun; 135(6):493-7. PubMed ID: 10850649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
    Sato Y; Ando K; Fujita T
    Hypertension; 1987 Jan; 9(1):81-7. PubMed ID: 2878880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of area postrema on DOCA-salt induced hypertension in rat].
    Lin S; Ni D; Fan S
    Zhonghua Yi Xue Za Zhi; 1996 Jun; 76(6):423-6. PubMed ID: 9275484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathophysiological role of renal dopamine and kallikrein in deoxycorticosterone acetate (DOCA)-salt treated rats.
    Ishiguro T; Shimamoto K; Ura N; Nomura N; Hayashi M; Iimura O
    Clin Exp Hypertens; 1995 Nov; 17(8):1287-99. PubMed ID: 8563702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of sympathetic nerve activity and natriuresis in the antihypertensive actions of potassium in NaCl hypertension.
    Fujita T; Sato Y; Ando K
    Jpn Circ J; 1983 Oct; 47(10):1227-31. PubMed ID: 6632175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH; Venema RC; Pollock DM
    Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension.
    Oyekan AO; McAward K; Conetta J; Rosenfeld L; McGiff JC
    Am J Physiol; 1999 Mar; 276(3):R766-75. PubMed ID: 10070137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sympathetic nervous system in clinical and experimental hypertension.
    Oparil S
    Kidney Int; 1986 Sep; 30(3):437-52. PubMed ID: 3537449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.